Selenium
nanoparticles (SeNPs) are important and safe food and
feed additives that can be used for dietary supplementation. In this
study, a mutagenic strain of Saccharomyces boulardii was employed to obtain biologically synthesized SeNPs (BioSeNPs)
with the desired particle size by controlling the dosage and duration
of sodium selenite addition, and the average particle size achieved
was 55.8 nm with protease A encapsulation. Transcriptomic analysis
revealed that increased expression of superoxide dismutase 1 (SOD1)
in the mutant strain effectively promoted the synthesis of BioSeNPs
and the formation of smaller nanoparticles. Under sodium selenite
stress, the mutant strain exhibited significantly increased expression
of glutathione peroxidase 2 (GPx2), which was significantly greater
in the mutant strain than in the wild type, facilitating the synthesis
of glutathione selenol and providing abundant substrates for the production
of BioSeNPs. Furthermore, based on the experimental results and transcriptomic
analysis of relevant genes such as sod1, gpx2, the thioredoxin reductase 1 gene (trr1) and the thioredoxin reductase 2 gene (trr2), a
yeast model for the size-controlled synthesis of BioSeNPs was constructed.
This study provides an important theoretical and practical foundation
for the green synthesis of controllable-sized BioSeNPs or other metal
nanoparticles with potential applications in the fields of food, feed,
and biomedicine.